ATE67495T1 - 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine. - Google Patents

4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine.

Info

Publication number
ATE67495T1
ATE67495T1 AT86116674T AT86116674T ATE67495T1 AT E67495 T1 ATE67495 T1 AT E67495T1 AT 86116674 T AT86116674 T AT 86116674T AT 86116674 T AT86116674 T AT 86116674T AT E67495 T1 ATE67495 T1 AT E67495T1
Authority
AT
Austria
Prior art keywords
alkyl
pyridinyl
hexahydro
tetrahydro
3pyridinyl
Prior art date
Application number
AT86116674T
Other languages
English (en)
Inventor
Juan C Jaen
Lawrence D Wise
Haile Tecle
Stephen C Bergmeier
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE67495T1 publication Critical patent/ATE67495T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT86116674T 1985-12-02 1986-12-01 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine. ATE67495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/803,697 US4650805A (en) 1985-12-02 1985-12-02 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
EP86116674A EP0234011B1 (de) 1985-12-02 1986-12-01 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamine und 4-(Hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamine

Publications (1)

Publication Number Publication Date
ATE67495T1 true ATE67495T1 (de) 1991-10-15

Family

ID=25187207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86116674T ATE67495T1 (de) 1985-12-02 1986-12-01 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine.

Country Status (7)

Country Link
US (2) US4650805A (de)
EP (1) EP0234011B1 (de)
JP (1) JPS62145081A (de)
AT (1) ATE67495T1 (de)
DE (1) DE3681581D1 (de)
ES (1) ES2039196T3 (de)
GR (1) GR3002841T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE67493T1 (de) * 1985-02-04 1991-10-15 Bayer Agrochem Kk Heterocyclische verbindungen.
US5001138B1 (en) * 1985-02-04 1998-01-20 Bayer Agrochem Kk Heterocyclic compounds
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
USRE34242E (en) * 1986-04-29 1993-05-04 Akzo N.V. Amino-oxazole compounds having dopaminergic activity
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5324723A (en) * 1987-09-10 1994-06-28 Merck Sharpe & Dohme Ltd. Oxazoles and thiazoles for the treatment of senile dementia
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
EP0372125A1 (de) * 1988-11-08 1990-06-13 Akzo N.V. Oxazol und Thiazol-Derivate
IE911994A1 (en) * 1990-07-03 1992-01-15 Akzo Nv 5-isothiazolamine derivatives
AU2003301513A1 (en) * 2003-08-04 2005-02-15 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
WO2007037543A1 (ja) * 2005-09-29 2007-04-05 Banyu Pharmaceutical Co., Ltd. ビアリールアミド誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1062245B (de) * 1957-10-17 1959-07-30 Ciba Geigy Verfahren zur Herstellung von 2-Amino-4-pyridyl-(2')-thiazol und seinen Salzen
JPS5835186A (ja) * 1981-08-25 1983-03-01 Mitsui Toatsu Chem Inc ジカルボキシアミノチアゾール誘導体およびそれを含有する免疫調節組成物
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4649146A (en) * 1983-01-31 1987-03-10 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives and pharmaceutical composition comprising the same
DE3486009T2 (de) * 1983-09-09 1993-04-15 Takeda Chemical Industries Ltd 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung.
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity

Also Published As

Publication number Publication date
US4739067A (en) 1988-04-19
DE3681581D1 (de) 1991-10-24
ES2039196T3 (es) 1993-09-16
EP0234011B1 (de) 1991-09-18
JPS62145081A (ja) 1987-06-29
US4650805A (en) 1987-03-17
EP0234011A1 (de) 1987-09-02
GR3002841T3 (en) 1993-01-25

Similar Documents

Publication Publication Date Title
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69006052D1 (de) 19-Nor-Vitamin-D-Derivate.
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE3681581D1 (de) 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamine und 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamine.
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
HUT46319A (en) Process for producing new, repeatedly oxygenated labdane derivatives and pharmaceutical compositions comprising these compounds as active ingredient
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DK249288A (da) Substituerede silylalkylenaminer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.